Initiator Pharma Future Growth
Future criteria checks 5/6
Initiator Pharma is forecast to grow earnings and revenue by 43.4% and 36.1% per annum respectively. EPS is expected to grow by 43.6% per annum. Return on equity is forecast to be 15% in 3 years.
Key information
43.4%
Earnings growth rate
43.6%
EPS growth rate
Biotechs earnings growth | 39.2% |
Revenue growth rate | 36.1% |
Future return on equity | 15.0% |
Analyst coverage | Low |
Last updated | 23 Feb 2024 |
Recent future growth updates
Recent updates
Health Check: How Prudently Does Initiator Pharma (STO:INIT) Use Debt?
Feb 27Is Initiator Pharma (STO:INIT) Using Debt In A Risky Way?
May 20Is Initiator Pharma (STO:INIT) Using Debt In A Risky Way?
Jan 06We're Not Worried About Initiator Pharma's (STO:INIT) Cash Burn
Oct 26We're Not Very Worried About Initiator Pharma's (NGM:INIT) Cash Burn Rate
Jun 12Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2025 | 51 | 19 | 75 | 75 | 1 |
12/31/2024 | 161 | 103 | 43 | 43 | 1 |
12/31/2023 | N/A | -23 | -18 | -18 | N/A |
9/30/2023 | N/A | -27 | -28 | -28 | N/A |
6/30/2023 | N/A | -29 | -29 | -29 | N/A |
3/31/2023 | N/A | -33 | -30 | -30 | N/A |
12/31/2022 | N/A | -38 | -33 | -33 | N/A |
9/30/2022 | N/A | -40 | -32 | -32 | N/A |
6/30/2022 | N/A | -43 | -47 | -47 | N/A |
3/31/2022 | N/A | -34 | -40 | -40 | N/A |
12/31/2021 | N/A | -21 | -34 | -34 | N/A |
9/30/2021 | N/A | -16 | -29 | -29 | N/A |
6/30/2021 | N/A | -10 | -11 | -11 | N/A |
3/31/2021 | N/A | -8 | -10 | -10 | N/A |
12/31/2020 | N/A | -9 | -8 | -8 | N/A |
9/30/2020 | N/A | -10 | -8 | -8 | N/A |
6/30/2020 | N/A | -9 | -7 | -7 | N/A |
3/31/2020 | N/A | -9 | -8 | -8 | N/A |
12/31/2019 | N/A | -8 | -9 | -9 | N/A |
9/30/2019 | N/A | -7 | -7 | -7 | N/A |
6/30/2019 | N/A | -9 | -7 | -7 | N/A |
3/31/2019 | N/A | -8 | -10 | -10 | N/A |
12/31/2018 | N/A | -10 | -14 | -14 | N/A |
9/30/2018 | N/A | -13 | -16 | -16 | N/A |
6/30/2018 | N/A | -11 | -14 | -14 | N/A |
3/31/2018 | N/A | -10 | -11 | -11 | N/A |
12/31/2017 | N/A | -9 | -8 | -8 | N/A |
9/30/2017 | N/A | -7 | N/A | -4 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: INIT is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (1%).
Earnings vs Market: INIT is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: INIT is expected to become profitable in the next 3 years.
Revenue vs Market: INIT's revenue (36.1% per year) is forecast to grow faster than the Swedish market (1.7% per year).
High Growth Revenue: INIT's revenue (36.1% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: INIT's Return on Equity is forecast to be low in 3 years time (15%).